Rose Garden IVS: Financial statements 2019
CVR: 38254944
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Rose Garden IVS (CVR 38254944) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -500 the year before. Equity in the 2019 report amounted to DKK 2,170. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 2,170
- Total Assets
- DKK 2,170
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 | 0 | 0 | 2K | - |
| 2018 | 0 | -500 | -500 | 4K | - |
| 2017 | 0 | -670 | -51K | -45K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Rose Garden IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -500.
About Rose Garden IVS
Rose Garden IVS was a Danish company of the type Iværksætterselskab based in København Ø, founded in 2016. The company has been dissolved on 28 January 2022. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 155 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK 2,325.